Skip to main content
logo
Hefei Lifeon Pharmaceutical Co., Ltd. (SHE:003020)
China flag China · Delayed Price · Currency is CNY
24.39
+0.32 (1.33%)
At close: Mar 30, 2026

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2023FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2014
Period Ending
Dec '24 Dec '23 Jan '23 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '14
Pharmaceutical Industry
1.38B1.16B965.52M891.21M611.77M
Pharmaceutical Industry Growth
18.92%19.93%8.34%45.68%24.52%
Pharmaceutical Retail
110.53M134.39M129.69M95.59M81.04M
Pharmaceutical Retail Growth
-17.75%3.62%35.68%17.94%11.36%
Unallocated Other Business Income
30.88M14.25M8.86M11.77M12.73M
Unallocated Other Business Income Growth
116.69%60.75%-24.67%-7.60%64.10%
Pharmaceutical Wholesale Distribution
-594.17M1.48B1.27B1.19B
Pharmaceutical Wholesale Distribution Growth
--59.72%15.74%7.23%10.25%
Total
1.52B1.90B2.58B2.27B1.89B
Total Growth
-20.11%-26.31%13.46%20.01%14.80%

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2023FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2014
Period Ending
Dec '24 Dec '23 Jan '23 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '14
Overseas
2.80M2.45M725.75K3.15M1.96M
Overseas Growth
14.30%238.07%-76.93%60.22%-27.85%
China
1.52B1.90B---
China Growth
-20.16%----
East China
--1.90B1.67B1.52B
East China Growth
--13.85%9.75%13.26%
North China
--171.17M131.41M96.98M
North China Growth
--30.26%35.50%67.70%
Central China
--211.01M180.90M92.34M
Central China Growth
--16.64%95.90%-1.19%
Southern China
--102.24M113.36M71.01M
Southern China Growth
---9.80%59.64%2.68%
Southwest China
--107.78M106.20M65.06M
Southwest China Growth
--1.49%63.24%46.05%
Northeast China
--54.97M48.23M30.60M
Northeast China Growth
--13.97%57.63%15.07%
Northwestern China
--35.46M24.69M18.94M
Northwestern China Growth
--43.65%30.30%18.40%
Total
1.52B1.90B2.58B2.27B1.89B
Total Growth
-20.11%-26.31%13.46%20.01%14.80%
Source: S&P Global Market Intelligence.